>
Switch to:

BridgeBio Pharma Stock Based Compensation

: $56.32 Mil (TTM As of Sep. 2020)
View and export this data going back to 2019. Start your Free Trial

BridgeBio Pharma's Stock Based Compensation for the three months ended in Sep. 2020 was $17.70 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2020 was $56.32 Mil.


BridgeBio Pharma Stock Based Compensation Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19
Stock Based Compensation 1.84 6.07 21.37

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Stock Based Compensation Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.78 10.01 10.22 18.39 17.70

BridgeBio Pharma Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2020 was 10.01 (Dec. 2019 ) + 10.22 (Mar. 2020 ) + 18.39 (Jun. 2020 ) + 17.7 (Sep. 2020 ) = $56.32 Mil.


BridgeBio Pharma Stock Based Compensation Related Terms


BridgeBio Pharma Stock Based Compensation Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)